4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0001567619-23-000327
Options or other derivatives
- Chief Business - Strategy Off acquired 106,648 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lin Patrick Chief Business - Strategy Off | 2022-12-31 | Grant or award · Restricted Stock Units | +10,851 | 344,531 | D: show line 1 in the form | ||
| Lin Patrick Chief Business - Strategy Off | 2023-01-01 | Grant or award · Restricted Stock Units | +55,107 | 399,638 | D: show line 2 in the form | ||
| Lin Patrick Chief Business - Strategy Off | 2023-01-01 | Grant or award · Restricted Stock Units | +40,690 | 440,328 | D: show line 3 in the form |
Loading xslF345X03/doc1.xml…